TrialEuropean journal of nuclear medicine and molecular imaging2017

[18F]FDG PET/CT-based response assessment of stage IV non-small cell lung cancer treated with paclitaxel-carboplatin-bevacizumab with or without nitroglycerin patches.

Evelyn E C de Jong et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.